Steve Schonfeld’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.76M Buy
+7,732
New +$1.96M 0.01% 1238
2026
Q1
– Sell
-2,581
Closed -$550K – 2201
2025
Q4
$550K Sell
2,581
-35,669
-93% -$7.37M ﹤0.01% 1362
2025
Q3
$7.6M Buy
38,250
+36,379
+1,944% +$6.79M 0.04% 433
2025
Q2
$323K Sell
1,871
-58,504
-97% -$9.5M ﹤0.01% 1673
2025
Q1
$9.41M Sell
60,375
-78,218
-56% -$11.2M 0.06% 344
2024
Q4
$19.1M Sell
138,593
-89,932
-39% -$11.8M 0.11% 164
2024
Q3
$34.1M Buy
228,525
+130,384
+133% +$17.6M 0.23% 56
2024
Q2
$13.4M Sell
98,141
-3,859
-4% -$525K 0.09% 270
2024
Q1
$15.4M Sell
102,000
-22,901
-18% -$3.27M 0.1% 234
2023
Q4
$15.7M Buy
124,901
+86,001
+221% +$8.57M 0.1% 225
2023
Q3
$3.64M Buy
38,900
+7,700
+25% +$720K 0.03% 640
2023
Q2
$2.78M Buy
31,200
+10,300
+49% +$896K 0.02% 650
2023
Q1
$2.24M Sell
20,900
-46,958
-69% -$5.37M 0.02% 661
2022
Q4
$8.29M Buy
67,858
+52,358
+338% +$6.08M 0.07% 347
2022
Q3
$1.6M Buy
+15,500
New +$1.47M 0.01% 980
2022
Q1
– Sell
-12,800
Closed -$1.72M – 2579
2021
Q4
$1.72M Buy
+12,800
New +$1.9M 0.02% 743
2021
Q3
– Sell
-13,900
Closed -$1.83M – 2146
2021
Q2
$1.83M Buy
13,900
+5,800
+72% +$773K 0.02% 744
2021
Q1
$1.04M Sell
8,100
-16,520
-67% -$2.51M 0.01% 873
2020
Q4
$4.11M Sell
24,620
-3,295
-12% -$545K 0.06% 442
2020
Q3
$4.31M Buy
27,915
+13,415
+93% +$1.93M 0.08% 329
2020
Q2
$2.14M Buy
+14,500
New +$1.99M 0.06% 388
2020
Q1
– Sell
-11,400
Closed -$1.59M – 1131
2019
Q4
$1.59M Sell
11,400
-28,400
-71% -$3.16M 0.04% 386
2019
Q3
$3.83M Sell
39,800
-51,700
-57% -$5.77M 0.11% 200
2019
Q2
$10.5M Sell
91,500
-92,900
-50% -$11.1M 0.37% 64
2019
Q1
$21.7M Buy
+184,400
New +$16.1M 0.75% 16
2018
Q3
– Sell
-15,000
Closed -$997K – 797
2018
Q2
$997K Buy
+15,000
New +$986K 0.05% 392
2017
Q4
– Sell
-9,763
Closed -$354K – 738
2017
Q3
$354K Buy
+9,763
New +$280K 0.03% 428

Other funds holding ASND

Steve Schonfeld's ASND Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Ascendis Pharma (ASND) in Q3 2026: 7,732 shares worth $1.76M. The stake represents 0.01% of the portfolio and ranks #1238 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in ASND as recently as Q4 2025.

Steve Schonfeld first reported a position in ASND in Q3 2017 and has held it in 27 quarters since. The position peaked at $34.1M in Q3 2024. 344 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • Steve Schonfeld held 7,732 shares of Ascendis Pharma worth $1.76M as of Q3 2026.
  • Ascendis Pharma was a new Steve Schonfeld position in Q3 2026.
  • Ascendis Pharma made up 0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1238 holding.
  • Steve Schonfeld first reported a position in Ascendis Pharma in Q3 2017 and has held it in 27 quarters since.
  • Steve Schonfeld's Ascendis Pharma position peaked at $34.1M in Q3 2024.
  • 344 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.